FDA Inspection 900112 — California Pharmacy & Compounding Center

California Pharmacy & Compounding Center — FEI 3004600090

The FDA completed an inspection of California Pharmacy & Compounding Center on October 17, 2014 in Newport Beach, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 17, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newport Beach, CA (United States)

Citations

IDCFRDescription
154021 CFR 211.125(a)Strict control not exercised over labeling issued
202721 CFR 211.192Investigations of discrepancies, failures
440221 CFR 211.192Written record of investigation incomplete